Does RUXOLITINIB Cause Hepatic enzyme increased? 201 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 201 reports of Hepatic enzyme increased have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.3% of all adverse event reports for RUXOLITINIB.
201
Reports of Hepatic enzyme increased with RUXOLITINIB
0.3%
of all RUXOLITINIB reports
17
Deaths
67
Hospitalizations
How Dangerous Is Hepatic enzyme increased From RUXOLITINIB?
Of the 201 reports, 17 (8.5%) resulted in death, 67 (33.3%) required hospitalization, and 4 (2.0%) were considered life-threatening.
Is Hepatic enzyme increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 201 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
TOFACITINIB (6,269)
Which RUXOLITINIB Alternatives Have Lower Hepatic enzyme increased Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE